Comparison of the pharmacokinetics of an oral extended‐release capsule formulation of carbidopa‐levodopa (IPX066) with immediate‐release carbidopa‐levodopa (Sinemet®), sustained‐release carbidopa‐levodopa (Sinemet® CR), and carbidopa‐levodopa‐entacapone (Stalevo®)

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 9, 2015-09 ,pp. : 995-1003

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Lesser of Two Adverse Reactions

By Chakraborti Chayan   Egan John  

Joint Commission Journal on Quality and Patient Safety, Vol. 36, Iss. 1, 2010-01 ,pp. : 22-27

Joint Commission Resources

Access to resources Recommend Favorite

Pharmacogenomics and adverse drug reactions

By Amur Shashi   Zineh Issam   Abernethy Darrell R   Huang Shiew-Mei   Lesko Lawrence J  

Personalized Medicine, Vol. 7, Iss. 6, 2010-11 ,pp. : 633-642

Future Medicine

Access to resources Recommend Favorite

11 Adverse Reactions

By  

Transfusion Medicine and Hemotherapy, Vol. 36, Iss. 6, 2009-12 ,pp. : 465-478

Karger

Access to resources Recommend Favorite

Prevalence of Adverse Drug Reactions

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 38, Iss. 6, 1990-06 ,pp. : 722-722

John Wiley & Sons Inc

Access to resources Recommend Favorite